ClinicalTrials.Veeva

Menu

High Intensity Light Therapy in Alzheimer's Disease

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 3

Conditions

Alzheimer's Disease
Dementia

Treatments

Device: high-intensity light therapy

Study type

Interventional

Funder types

NIH

Identifiers

NCT00065689
SloaneP
R01AT000212-01A1

Details and patient eligibility

About

The purpose of this study is to determine whether bright light improves the sleep, mood, and behavior of persons with Alzheimer's disease and related dementias (AD) who live in long-term care settings and, if so, to determine the best timing for the light therapy. The light levels being used in the study have been shown to improve depression in persons with seasonal affective disorder (SAD) and to relieve sleep problems in persons with jet lag and other body rhythm disturbances. Because persons with AD often will not remain still in front of a fluorescent panel, this project has involved renovations in the study units that provide for even, regulated, high-intensity light in all public areas of the study settings.

Full description

See Brief Summary

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of dementia
  • Residence on study units

Exclusion criteria

  • Bipolar disorder
  • Severe retinal (eye) disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems